Jeffrey Scott Riley - Mar 28, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role: Director
Signature: /s/ Jeffrey Scott Riley
Stock symbol: GANX
Transactions as of: Mar 28, 2024
Transactions value $: $115,770
Form type: 4
Date filed: 4/1/2024, 04:01 PM
Previous filing: Jun 26, 2023
Next filing: Jun 26, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GANX	Common Stock	Purchase	$116K	+30K		$3.86	30K	Mar 28, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.